View |
|
DR-X7781
|
Allopurinol
|
Purinase
|
300 mg
|
Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
22 January 2021
|
01 October 2025
|
View |
|
DR-X7970
|
Piribedil
|
Trivastal Retard 50
|
50mg
|
Tablet
|
-
|
Les Laboratoires Servier Industrie
|
France
|
Automatic Renewal
|
11 March 2021
|
09 January 2026
|
View |
|
DR-X8185
|
Betamethasone (as dipropionate)/ Salicylic Acid
|
DIPROSALIC
|
500 mcg/30 mg
|
Ointment
|
Anti-inflammatory/ Anti-pruritic/ Keratolytic
|
Manufacturer-PT. Merck Sharp Dohme Pharma Tbk
|
Indonesia
|
Renewal
|
19 December 2023
|
19 February 2029
|
View |
|
DR-X8346
|
Amoxicillin (As Trihydrate)
|
Pediamox
|
250 mg/5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Asian Antibiotics, Inc
|
Philippines
|
Automatic Renewal
|
10 April 2023
|
25 June 2028
|
View |
|
DR-X8475
|
Benzylpenicillin Sodium
|
None
|
5,000,000 Units
|
Sterile Powder For Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
YSS Laboratories Co., Inc.
|
Philippines
|
Automatic Renewal
|
31 March 2021
|
01 August 2026
|
View |
|
DR-X8493
|
Trimipramine maleate
|
Surmontil
|
25mg
|
Antidepresant
|
Antidepressant
|
Famar Lyon
|
France
|
Automatic Renewal
|
24 June 2021
|
28 September 2026
|
View |
|
DR-X8596
|
Cefaclor
|
Ceclor
|
125mg/5mL
|
Powder For Suspension (Strawberry Flavor)
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
-
|
30 March 2020
|
08 May 2025
|
View |
|
DR-X8671
|
Allopurinol
|
Llanol
|
300 mg
|
Tablet
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
-
|
11 May 2020
|
30 May 2025
|
View |
|
DR-X8675
|
Guaifenesin + Sodium Citrate
|
Mucobron
|
100 mg/300 mg per 5 mL
|
Syrup
|
-
|
Medi-Rx, Inc.
|
Philippines
|
-
|
08 September 2021
|
18 January 2026
|
View |
|
DR-X885
|
Furosemide
|
FRUSEMA
|
10 mg/mL (20 mg/2 mL)
|
Solution for Injection (IM/IV)
|
Diuretic (Sulfonamide)
|
Amherst Parenterals, Inc.
|
Philippines
|
Renewal
|
08 August 2022
|
14 October 2027
|
View |
|
DR-X9017
|
Diphenhydramine Hydrochloride
|
None
|
50mg/mL
|
Solution for Injection (IM/IV)
|
ANTICHOLINERGIC / ANTIHISTAMINE
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
29 September 2021
|
09 November 2026
|
View |
|
DR-X9100
|
Amoxicillin (as trihydrate)
|
Pediamox
|
100 mg/ mL
|
Powder For Suspension (Oral Drops)
|
Antibacterial (Penicillin)
|
Asian Antibiotics, Inc
|
Philippines
|
Renewal
|
13 December 2023
|
16 February 2029
|
View |
|
DR-X9339
|
Bromhexine Hydrochloride
|
Mucosform
|
5mgper 5mL
|
Elixir/Syrup
|
Mucolytics
|
Lejal Laboratories Inc.
|
Philippines
|
Renewal
|
04 December 2021
|
09 January 2027
|
View |
|
DR-X9749
|
Amoxicillin (Trihydrate)
|
Teramoxyl
|
125 mg/ 5 mL
|
Powder For Suspension
|
Antibacterial (Penicillin)
|
Drugmaker's Laboratories Inc.
|
Philippines
|
Renewal
|
16 February 2024
|
07 April 2029
|
View |
|
DR-X9928
|
Fluocinolone Acetonide
|
Synalar 10
|
100 mcg/ g (0.01% w/w)
|
Ointment
|
-
|
Interphil Laboratories, Inc.
|
Philippines
|
Renewal
|
09 September 2020
|
04 October 2025
|
View |
|
DR-XY
|
Cetrorelix (as acetate)
|
None
|
250 mcg
|
Lyophilized Powder For Injection (Iv)
|
-
|
Gufic Biosciences Limited.
|
India
|
-
|
28 August 2020
|
28 August 2025
|
View |
|
DR-XY 13319
|
Balanced Multiple Maintenance Solution With 5% Dextrose (see formulation on reverse side)
|
Multi-Ion Mb In D5W
|
Each 100 mL contains 5 g Dextrose Monohydrate; 260 mg Sodium Lactate, Anhydrous; 141 mg Potassium Chloride; 15 mg Monobasic Potassium Phosphate; 21.4 mg Monobasic Sodium Phosphate; 14.2 mg Magnesium Chloride & 20 mg Sodium Metabisulfite
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc
|
Philippines
|
-
|
08 September 2020
|
16 October 2025
|
View |
|
DR-XY 40138
|
5% Dextrose In 0.9% Sodium Chloride (See formulation in reverse side
|
None
|
Each 100 mL contains 5 g Dextrose Monohydrate & 900 mg Sodium Chloride
|
Solution For Iv Infusion
|
-
|
Euro-Med Laboratories Phil., Inc
|
Philippines
|
-
|
03 September 2020
|
30 September 2025
|
View |
|
DR-XY092
|
Policresulen+Cinchocaine hydrochloride
|
Faktu
|
100mg/2.5mg
|
Suppository
|
Antihemorrhoidal
|
|
|
Renewal
|
29 June 2024
|
06 October 2029
|
View |
|
DR-XY093
|
Policresulen+Cinchocaine HCl
|
Faktu
|
50mg/10mg per gram
|
Ointment
|
Antihemorrhoidal
|
Takeda GmbH
|
Germany
|
Renewal
|
12 June 2024
|
03 August 2029
|